In the lab, Dr. Huard is developing cutting-edge therapies for bone, Regenerate cartilage and peripheral nerve and skeletal muscle damaged after sports and military violations repair.. ###Dr. Huard and colleagues in the Stem Cell explore explore developing numerous therapeutic uses for the population of muscle stem cells, the team identifies. One of the most promising uses could for the treatment of Duchenne muscular dystrophy , one genetic disease that affects a boys of 3500.
Research Center. This study is our belief that this novel population of stem cells discovered in our laboratory tremendous promise for the future of regenerative medicine has particularly confirms myoendothelial cell potential as a therapy for show suffered myocardial infarction show, said Dr. Huard, the Henry J. Mankin Professor and vice chairman for research in the Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine. the most important benefit of our approach is that a therapy, it would be an autologous transplant. This means that for a patient who suffers a heart attack, we would from his muscle biopsy from his muscles, isolating and purifying the cells and again myoendothelial they inject into the injured cardiac muscle, whereby. The risk of rejection by the introduction of foreign cells ..An additional 150,000 intended collaborate Hersch and the Huntington Studygroup, about a stage III study the spring 2008 after the completion from chronic toxicology study that is currently under way initiate Avicena order Huntington Disease Clinical Program in Phase III and Advance. – The elected R & D Directions magazine short HD-02 one of the ‘100 Great its Investigational Drugs of 2007’in the output of March 2007.